2-chloroadenosine has been researched along with Neutropenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishizaka, A; Kanazawa, M; Kobayashi, K; Nakamura, H; Sakamaki, F; Sawafuji, M; Sayama, K; Soejima, K; Tasaka, S; Terashima, T; Urano, T; Waki, Y; Yamaguchi, K | 1 |
| Abhyankar, D; Advani, SH; Bajpai, S; Gopal, R; Nair, CN; Saikia, T | 1 |
1 trial(s) available for 2-chloroadenosine and Neutropenia
| Article | Year |
|---|---|
2-CdA in the treatment of hairy cell leukaemia.
Topics: 2-Chloroadenosine; Adult; Antimetabolites, Antineoplastic; Deoxyadenosines; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neutropenia; Survival Rate; Treatment Outcome | 2001 |
1 other study(ies) available for 2-chloroadenosine and Neutropenia
| Article | Year |
|---|---|
Attenuation by intravenous 2-chloroadenosine of acute lung injury induced by live escherichia coli or latex particles added to endotoxin in the neutropenic state.
Topics: 2-Chloroadenosine; Acute Disease; Animals; Endotoxins; Escherichia coli; Escherichia coli Infections; Guinea Pigs; Injections, Intravenous; Lung Diseases; Microspheres; Neutropenia; Specific Pathogen-Free Organisms; Tumor Necrosis Factor-alpha | 2003 |